Prioult et al., 2005 - Google Patents
Allergenicity of acidic peptides from bovine β-lactoglobulin is reduced by hydrolysis with Bifidobacterium lactis NCC362 enzymesPrioult et al., 2005
- Document ID
- 17232471937409149022
- Author
- Prioult G
- Pecquet S
- Fliss I
- Publication year
- Publication venue
- International dairy journal
External Links
Snippet
Cow milk proteins, particularly β-lactoglobulin (BLG) are a leading cause of food allergy in children. In vivo, gastrointestinal hydrolysis of milk proteins decreases their allergenicity, but the intestinal microbiota also contributes to their breakdown. This study investigated the …
- 241000901050 Bifidobacterium animalis subsp. lactis 0 title abstract description 88
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Prioult et al. | Allergenicity of acidic peptides from bovine β-lactoglobulin is reduced by hydrolysis with Bifidobacterium lactis NCC362 enzymes | |
| Sütas et al. | Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG–derived enzymes | |
| Takahashí et al. | Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens | |
| Verhasselt | Neonatal tolerance under breastfeeding influence | |
| FI104465B (en) | Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use | |
| Isolauri et al. | Probiotics: effects on immunity | |
| AU2016247052B2 (en) | Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof | |
| Prioult et al. | Stimulation of interleukin-10 production by acidic β-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases | |
| RU2522282C2 (en) | Application of bifidobacterium strain for obtaining composition intended for prevention and/or treatment of manifestations of allergic type | |
| RU2294366C2 (en) | Transformed lactic-acid bacteria reducing susceptibility to allergic reactions and uses thereof | |
| Low et al. | Effect of dietary whey protein concentrate on primary and secondary antibody responses in immunized BALB/c mice | |
| Shin et al. | Preventive effects of a probiotic mixture in an ovalbumin-induced food allergy model | |
| Mallet et al. | The immunopotentiating effects of shark-derived protein hydrolysate | |
| MX2007012697A (en) | Infant formula with probiotics. | |
| Gil et al. | Interaction of early diet and the development of the immune system | |
| Wróblewska et al. | Whey prefermented with beneficial microbes modulates immune response and lowers responsiveness to milk allergens in mouse model | |
| He et al. | Effect of orally administered non‐viable Lactobacillus cells on murine humoral immune responses | |
| AU2013407963B2 (en) | Newly identified peptides for use in the induction of oral tolerance in young mammals | |
| AU2013407963A1 (en) | Newly identified peptides for use in the induction of oral tolerance in young mammals | |
| Isolauri et al. | New functional foods in the treatment of food allergy | |
| Pescuma et al. | Hydrolysate of β-lactoglobulin by Lactobacillus delbrueckii subsp. bulgaricus CRL 656 suppresses the immunoreactivity of β-lactoglobulin as revealed by in vivo assays | |
| Xu et al. | Effect of lactic acid bacteria fermentation on cow milk allergenicity and antigenicity: A review | |
| Görtler et al. | Characterization of antigens and allergens in hypo-allergenic infant formulae | |
| Matar et al. | Bioactive peptides from fermented foods: their role in the immune system | |
| Knowles et al. | Immunomodulation by dairy ingredients: potential for improving health |